- Home
- CDXS vs FMAO Comparison
CDXS vs FMAO Comparison
Compare CDXS & FMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- FMAO
- Stock Information
- Founded
- CDXS 2002
- FMAO 1897
- Country
- CDXS United States
- FMAO United States
- Employees
- CDXS N/A
- FMAO N/A
- Industry
- CDXS Major Chemicals
- FMAO Savings Institutions
- Sector
- CDXS Industrials
- FMAO Finance
- Exchange
- CDXS Nasdaq
- FMAO Nasdaq
- Market Cap
- CDXS 254.3M
- FMAO 359.3M
- IPO Year
- CDXS 2010
- FMAO N/A
- Fundamental
- Price
- CDXS $2.47
- FMAO $25.57
- Analyst Decision
- CDXS Buy
- FMAO
- Analyst Count
- CDXS 2
- FMAO 0
- Target Price
- CDXS $11.00
- FMAO N/A
- AVG Volume (30 Days)
- CDXS 1.1M
- FMAO 15.2K
- Earning Date
- CDXS 10-30-2025
- FMAO 10-29-2025
- Dividend Yield
- CDXS N/A
- FMAO 3.37%
- EPS Growth
- CDXS N/A
- FMAO 38.39
- EPS
- CDXS N/A
- FMAO 2.16
- Revenue
- CDXS $57,164,000.00
- FMAO $108,632,000.00
- Revenue This Year
- CDXS $12.88
- FMAO $1.60
- Revenue Next Year
- CDXS $21.64
- FMAO $13.77
- P/E Ratio
- CDXS N/A
- FMAO $12.16
- Revenue Growth
- CDXS N/A
- FMAO 13.86
- 52 Week Low
- CDXS $1.90
- FMAO $20.88
- 52 Week High
- CDXS $6.08
- FMAO $34.15
- Technical
- Relative Strength Index (RSI)
- CDXS 50.21
- FMAO 45.49
- Support Level
- CDXS N/A
- FMAO $25.67
- Resistance Level
- CDXS $2.54
- FMAO $26.50
- Average True Range (ATR)
- CDXS 0.11
- FMAO 0.76
- MACD
- CDXS -0.10
- FMAO -0.09
- Stochastic Oscillator
- CDXS 88.35
- FMAO 12.91
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company based in Ohio. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.